Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Current Assets (2020 - 2025)

Historic Current Assets for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $349.2 million.

  • Arcutis Biotherapeutics' Current Assets fell 1758.14% to $349.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $349.2 million, marking a year-over-year decrease of 1758.14%. This contributed to the annual value of $335.8 million for FY2024, which is 163.09% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Current Assets stood at $349.2 million for Q3 2025, which was down 1758.14% from $332.8 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' Current Assets' 5-year high stood at $496.7 million during Q3 2022, with a 5-year trough of $281.5 million in Q3 2023.
  • Moreover, its 5-year median value for Current Assets was $367.7 million (2023), whereas its average is $380.2 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Current Assets skyrocketed by 9666.6% in 2021, and later tumbled by 4331.85% in 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Current Assets (Quarter) stood at $402.8 million in 2021, then grew by 8.6% to $437.4 million in 2022, then dropped by 24.46% to $330.4 million in 2023, then increased by 1.63% to $335.8 million in 2024, then grew by 3.99% to $349.2 million in 2025.
  • Its Current Assets stands at $349.2 million for Q3 2025, versus $332.8 million for Q2 2025 and $323.7 million for Q1 2025.